Sort
11,323 grants matching “glioblastoma”
TECH Core
$513,261Kevin William Eliceiri · University Of Minnesota · U54 · FY2023 · CA
TRANSLATIONAL CLINICAL TRIALS FOR PRIMARY CNS TUMORS
$513,111David Reardon · Duke University · P50 · FY2012 · NS
Clinical and Translational Investigations of Immune Suppression and Immune Modulation in Glioblastoma
$513,108Edjah Nduom · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Extrachromosomal DNA as a Targetable Mechanism in Glioblastoma
$513,071Roel Gw Verhaak · Jackson Laboratory · R01 · FY2022 · CA
Mechanisms of alternative splicing of pre-mRNA
$513,033James L. Manley · Columbia Univ New York Morningside · R01 · FY2015 · GM
Effect of Bone Marrow Cells on the Radiosensitivity of Brain and Mouth Cancers
$512,928John Martin Brown · Stanford University · R01 · FY2010 · CA
Assaying GBM growth and therapy response in single cells and tumorspheres (PQ17)
$512,621Keith L Ligon · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Therapeutic targeting of the SWI/SNF chromatin remodeler to regulate GBM chemosensitivity
$512,586Lawrence M Pfeffer · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA
Targeting tumor microenvironment by nanoimmunodrugs for glioma treatment
$512,558Alexander V Ljubimov · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Physical Limits of Quantitative SPECT
$512,444Brigham And Women'S Hospital · R01 · FY2005 · EB
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors
$512,053Justin S. Hanes · Johns Hopkins University · R01 · FY2017 · CA
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma
$512,013Charles S Cobbs · Swedish Medical Center, First Hill · R01 · FY2015 · CA
Targeted drug delivery system to overcome blood-brain barrier and therapeutic resistance to current standard of care in Glioblastoma
$511,948Meser M. Ali · Wayne State University · R01 · FY2025 · CA
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment
$511,916Sean Edward Lawler · Brown University · R01 · FY2023 · CA
Optimization of ultrasound-mediated drug delivery to the brain under clinically relevant conditions
$511,748Nathan J McDannold · Brigham And Women'S Hospital · R01 · FY2022 · EB
âPharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment responseâ
$511,747Robert C Rostomily · Methodist Hospital Research Institute · R01 · FY2024 · NS
Project 2 - Investigating Clinical and Biological Implications of a Novel Hypermethylated Subtype of Metastatic Castration Resistant Prostate Cancer (mCRPC)
$511,680Eric J Small · University Of California, San Francisco · P50 · FY2024 · CA
Project 4: Multi-modality Metabolic Imaging for Monitoring Molecular Sub-types of Glioma
$511,629Daniel B Vigneron · University Of California, San Francisco · P01 · FY2020 · CA
Understanding EGF receptor activation by growth factors and oncogenic mutations
$511,569Mark A. Lemmon · Yale University · R01 · FY2023 · CA
Targeting metabolic vulnerabilities in glioblastoma
$511,461David A. Nathanson · University Of California Los Angeles · R01 · FY2017 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$511,345Albert Folch · University Of Washington · R01 · FY2024 · CA
PEDIATRIC GLIOBLASTOMA THERAPIES BASED ON PATIENT-DERIVED STEM CELL RESOURCES
$511,136Fred Hutchinson Cancer Research Center · · FY2011 · Department of the Army
AN INFORMATIVE DIAGNOSIS OF A CANCER THROUGH MULTIPARAMETER SERUM ANALYSIS
$510,985Leroy E Hood · California Institute Of Technology · U54 · FY2009 · CA
RhoA and GPCR mediated transcriptional activation regulates glioblastoma
$510,883Joan Heller Brown · University Of California, San Diego · R01 · FY2020 · CA
CAREER: Multi-Gradient Microtissue Arrays to Analyze Patient-Derived Cancer Cell Modulation by Combinatorial Electrical and Chemical Stimulation
$510,660Scott S Verbridge · Virginia Polytechnic Institute And State University · · FY2017 · ENG